Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Annals of Internal Medicine
|
November 1, 1979
Is bromocriptine teratogenic?
R L Elton, H M Langrall
Neurology
|
February 1, 1985
Low dosages of bromocriptine added to levodopa in Parkinson's disease
M M Hoehn, R L Elton
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
January 1, 1972
Induction of ovulation as a biological assay for follicle stimulating hormone (FSH)
F E Harrington, R L Elton, F J Bex
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
December 1, 1973
Effect of chorionic gonadotropin on corpus luteum of the monkey
A H Surve, F E Harrington, R L Elton
Clinical Neuropharmacology
|
January 1, 1986
Bromocriptine: long-term low-dose therapy in Parkinson's disease
P F Teychenne, D Bergsrud, R L Elton, et al.
Acta Endocrinologica
|
October 1, 1970
The ovulatory effects of follicle stimulating hormone treated with chymotrypsin in chlorpromazine blocked rats
F E Harrington, F J Bex, R L Elton, et al.
Neurology
|
June 1, 1982
Bromocriptine: low-dose therapy in Parkinson disease
P F Teychenne, D Bergsrud, A Racy, et al.
Experientia
|
July 15, 1972
Allene versus acetylene in progestational steroids
E E Galantay, R V Coombs, I Basco, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1985
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study
M E Molitch, R L Elton, R E Blackwell, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1984
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kinetics
J L Borges, H F Schran, W S Evans, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Annals of Internal Medicine
|
November 1, 1979
Is bromocriptine teratogenic?
R L Elton, H M Langrall
Neurology
|
February 1, 1985
Low dosages of bromocriptine added to levodopa in Parkinson's disease
M M Hoehn, R L Elton
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
January 1, 1972
Induction of ovulation as a biological assay for follicle stimulating hormone (FSH)
F E Harrington, R L Elton, F J Bex
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
December 1, 1973
Effect of chorionic gonadotropin on corpus luteum of the monkey
A H Surve, F E Harrington, R L Elton
Clinical Neuropharmacology
|
January 1, 1986
Bromocriptine: long-term low-dose therapy in Parkinson's disease
P F Teychenne, D Bergsrud, R L Elton, et al.
Acta Endocrinologica
|
October 1, 1970
The ovulatory effects of follicle stimulating hormone treated with chymotrypsin in chlorpromazine blocked rats
F E Harrington, F J Bex, R L Elton, et al.
Neurology
|
June 1, 1982
Bromocriptine: low-dose therapy in Parkinson disease
P F Teychenne, D Bergsrud, A Racy, et al.
Experientia
|
July 15, 1972
Allene versus acetylene in progestational steroids
E E Galantay, R V Coombs, I Basco, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1985
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study
M E Molitch, R L Elton, R E Blackwell, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1984
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kinetics
J L Borges, H F Schran, W S Evans, et al.
Page
of 1